The objective of this contract is to develop preclinical rabbit immunogenicity data demonstrating efficacy of the selfadjuvantingand self-amplifying RNA platform.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93019C00008
- Awardee
-
PAI Life Sciences Inc. UEI MSMLUCM9DRT6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,184
Award facts
- Opportunity
-
- SBIRPHS20191 Solicitation number
- Nanoparticle Delivery of HIV Env Trimer for Inducing Somatic Hypermutation and bNAb Award Notice · Posted Jun 29, 2018
- Contract value 100% obligated
- $299,184.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98102, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $299,184 |
About this award
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $299,184 Firm Fixed Price definitive contract to PAI Life Sciences Inc., a self-certified small disadvantaged business, to develop preclinical rabbit immunogenicity data demonstrating the efficacy of a self-adjuvanting and self-amplifying ribonucleic acid (RNA) vaccine platform against human immunodeficiency virus type 1 (HIV-1). This contract was designated as a total small business set-aside.
The work is being performed as a Phase I Small Business Innovation Research (SBIR) program action. PAI Life Sciences has subcontracted with Duke University's Office of Research Administration Division, a private non-profit educational institution, to conduct the rabbit immunization studies and provide the resulting data to PAI Life Sciences.
Quick answers
Who was awarded contract 75N93019C00008?
75N93019C00008 was awarded to PAI Life Sciences Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 31, 2019.
How much is contract 75N93019C00008 worth?
The government has obligated $299,184 on 75N93019C00008.
Was contract 75N93019C00008 competed?
The extent of competition for 75N93019C00008 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award